Pay for bosses at Britain’s biggest companies should be benchmarked against global rivals to stay competitive, Rathbones Asset Management’s multi-asset boss has said.
David Coombs told Financial News investors should assess executive remuneration on a case-by-case basis. But in certain sectors such as pharmaceuticals, maintaining a level playing field with peers in the US and Europe is more relevant.
